SC
HALO icon

Shay Capital’s Halozyme HALO Stock Holding History

Shay Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$517K Buy
8,000
+3,000
+60% +$211K 0.04% 267
2025
Q4 		$337K Buy
+5,000
New +$336K 0.03% 342
2025
Q3 		– Sell
-30,000
Closed -$1.56M – 453
2025
Q2 		$1.56M Buy
30,000
+23,958
+397% +$1.36M 0.18% 87
2025
Q1 		$386K Buy
6,042
+1,542
+34% +$89.6K 0.06% 174
2024
Q4 		$215K Buy
+4,500
New +$231K 0.03% 250

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Shay Capital's HALO Position: Q1 2026 in Review

Shay Capital increased its Halozyme (HALO) stake by 60% in Q1 2026, buying an estimated $211K and bringing the position to 8,000 shares worth $517K. The position accounts for 0.04% of the portfolio, ranked #267.

Shay Capital first reported a position in HALO in Q4 2024 and has held it in 5 quarters since. The position peaked at $1.56M in Q2 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Shay Capital held 8,000 shares of Halozyme worth $517K as of Q1 2026.
  • Shay Capital bought 3,000 Halozyme shares in Q1 2026, an estimated $211K.
  • Halozyme made up 0.04% of Shay Capital's portfolio in Q1 2026, its #267 holding.
  • Shay Capital first reported a position in Halozyme in Q4 2024 and has held it in 5 quarters since.
  • Shay Capital's Halozyme position peaked at $1.56M in Q2 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Shay Capital's 13F filing for Q1 2026, filed 15 May 2026.